Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -86,431 | -48,004 | -160,928 | -116,806 | -71,636 |
| Depreciation Amortization | 4,188 | 2,190 | 14,080 | 12,101 | 10,618 |
| Accounts receivable | 778 | 968 | 36,654 | 36,942 | 35,646 |
| Other Working Capital | -3,177 | 614 | 19,182 | 23,371 | 26,192 |
| Other Operating Activity | 18,986 | 10,882 | -41,251 | -51,234 | -58,173 |
| Operating Cash Flow | $-65,656 | $-33,350 | $-132,263 | $-95,626 | $-57,353 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -35,922 | 17,400 | 118,818 | 73,284 | 47,914 |
| PPE Investments | -137 | -86 | -6,153 | -5,972 | -5,407 |
| Investing Cash Flow | $-36,059 | $17,314 | $112,665 | $67,312 | $42,507 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 94,822 | 95,488 | 85 | 265 | 265 |
| Other Financing Activity | 1,940 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $96,762 | $95,488 | $85 | $265 | $265 |
| Beginning Cash Position | 57,047 | 57,047 | 76,560 | 76,560 | 76,560 |
| End Cash Position | 52,094 | 136,499 | 57,047 | 48,511 | 61,979 |
| Net Cash Flow | $-4,953 | $79,452 | $-19,513 | $-28,049 | $-14,581 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,656 | -33,350 | -132,263 | -95,626 | -57,353 |
| Capital Expenditure | -137 | -86 | -6,153 | -5,972 | -5,407 |
| Free Cash Flow | -65,793 | -33,436 | -138,416 | -101,598 | -62,760 |